Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hoxton Farms is a private London-based biotechnology company developing cultivated pork fat as an ingredient for food manufacturers. Founded in 2020, the company combines stem cell biology, modular bioreactors, software and AI-enabled biomanufacturing to produce animal fat without conventional livestock production. Its lead product, Hoxton Fat, is positioned as a drop-in fat ingredient for meat products and meat alternatives, with an initial commercialization focus in Singapore and broader plans across APAC, the UK and North America. Hoxton Farms also presents its manufacturing stack as a scalable industrial biology platform that could extend beyond food into cosmetics, pharmaceuticals and sustainable materials. The company appears to be active and independent, with strategic partnerships including Sumitomo and Mitsui Chemicals.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hoxton.